BindingDB logo
myBDB logout

null

SMILES: OC(=O)c1nc(ccc1-c1cnn(Cc2cccc(n2)N2CCCC2)c1)N1CCc2cccc(C(=O)Nc3nc4ccccc4s3)c2C1

InChI Key: InChIKey=LTEDVMOGBGJUTC-UHFFFAOYSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 209076   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Bcl-2-like protein 1


(Homo sapiens (Human))
BDBM209076
PNG
(US9266877, 22)
Show SMILES OC(=O)c1nc(ccc1-c1cnn(Cc2cccc(n2)N2CCCC2)c1)N1CCc2cccc(C(=O)Nc3nc4ccccc4s3)c2C1
Show InChI InChI=1S/C36H32N8O3S/c45-34(41-36-39-29-10-1-2-11-30(29)48-36)27-9-5-7-23-15-18-43(22-28(23)27)32-14-13-26(33(40-32)35(46)47)24-19-37-44(20-24)21-25-8-6-12-31(38-25)42-16-3-4-17-42/h1-2,5-14,19-20H,3-4,15-18,21-22H2,(H,46,47)(H,39,41,45)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
6 -11.2n/an/an/an/an/an/a25



ABBVIE INC.

US Patent


Assay Description
The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluoresc...


US Patent US9266877 (2016)


BindingDB Entry DOI: 10.7270/Q2H41Q7V
More data for this
Ligand-Target Pair
Bcl-2-like protein 1


(Mus musculus (Mouse))
BDBM209076
PNG
(US9266877, 22)
Show SMILES OC(=O)c1nc(ccc1-c1cnn(Cc2cccc(n2)N2CCCC2)c1)N1CCc2cccc(C(=O)Nc3nc4ccccc4s3)c2C1
Show InChI InChI=1S/C36H32N8O3S/c45-34(41-36-39-29-10-1-2-11-30(29)48-36)27-9-5-7-23-15-18-43(22-28(23)27)32-14-13-26(33(40-32)35(46)47)24-19-37-44(20-24)21-25-8-6-12-31(38-25)42-16-3-4-17-42/h1-2,5-14,19-20H,3-4,15-18,21-22H2,(H,46,47)(H,39,41,45)
PDB

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 214n/an/an/an/a



ABBVIE INC.

US Patent


Assay Description
The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...


US Patent US9266877 (2016)


BindingDB Entry DOI: 10.7270/Q2H41Q7V
More data for this
Ligand-Target Pair